Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$253,782,934
-$80,845,580 QoQ
Shares Held
275,920
-11.4% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$68,062,980
PutShares
74,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CREDIT AGRICOLE S A holds $1,473,838,064 across 13 Drug Manufacturers - General names. LLY ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,977,566 | $587,235,563 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
275,920 | $253,782,934 | |
| 3 | ABBV |
AbbVie Inc.
|
897,538 | $195,205,535 | |
| 4 | JNJ |
Johnson & Johnson
|
511,911 | $125,131,522 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
625,798 | $87,217,463 | |
| 6 | MRK |
Merck & Co., Inc.
|
637,765 | $76,716,747 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
785,099 | $47,616,253 | |
| 8 | AMGN |
Amgen Inc
|
122,469 | $43,090,715 |
All Filings in LLY
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,062,980 | 74,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $253,782,934 | 275,920 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $88,661,108 | 82,500 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $334,628,514 | 311,375 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $60,277,000 | 79,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $231,518,616 | 303,432 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $26,842,075 | 32,500 | Put | Defined | 2025-05-14 | |
| 2025-03-31 | $291,580,088 | 353,041 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $254,773,124 | 330,017 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $18,914,000 | 24,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $168,179,758 | 189,832 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $15,060,980 | 17,000 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $161,705,392 | 178,605 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $12,222,630 | 13,500 | Put | Defined | 2024-08-13 | |
| 2024-03-31 | $10,502,460 | 13,500 | Put | Defined | 2024-05-14 | |
| 2024-03-31 | $47,564,472 | 61,140 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $21,998,814 | 37,739 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $12,416,294 | 23,116 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,905,124 | 16,856 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $4,292,750 | 12,500 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $5,391,693 | 15,700 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,083,072 | 24,828 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,596,500 | 32,771 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,030,401 | 43,273 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $16,309,342 | 56,952 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $16,278,471 | 58,933 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,209,341 | 61,499 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,396,622 | 58,368 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $11,992,908 | 64,195 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,261,340 | 48,930 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,816,068 | 59,560 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,444,534 | 33,162 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $73,521 | 530 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||